Report error Found 806 Enz. Inhib. hit(s) with all data for entry = 13247
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 1nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 12.2nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 13.4nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 14nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 14.6nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 14.7nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 15nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 15.5nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 15.9nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 16.3nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 18nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 18nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 18.7nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 18.8nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 19nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 19nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 19nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 19.3nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 19.8nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 20nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 20nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 20.1nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 20.7nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 21nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 21nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 21nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 21.3nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 21.3nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
Affinity DataIC50: 21.5nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 21.8nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:ATPase activity was measured using the ADP-Glo Kinase Assay following the manufacturers recommended protocol. More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 22nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [480-1251](Human)
Eikon Therapeutics
WIPO
Eikon Therapeutics
WIPO
Affinity DataIC50: 22nMAssay Description:WRN helicase core (8xHis-tev-WRN (480-1251)) was expressed in Sf9 insect cells and purified using HiTrap TALON affinity purification followed by hepa...More data for this Ligand-Target Pair






























